AU2002314319A1 - Use of adenosine a1 receptor agonists for the treatment of nociceptive pain - Google Patents

Use of adenosine a1 receptor agonists for the treatment of nociceptive pain

Info

Publication number
AU2002314319A1
AU2002314319A1 AU2002314319A AU2002314319A AU2002314319A1 AU 2002314319 A1 AU2002314319 A1 AU 2002314319A1 AU 2002314319 A AU2002314319 A AU 2002314319A AU 2002314319 A AU2002314319 A AU 2002314319A AU 2002314319 A1 AU2002314319 A1 AU 2002314319A1
Authority
AU
Australia
Prior art keywords
adenosine
treatment
receptor agonists
nociceptive pain
nociceptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002314319A
Inventor
Charanjit Bountra
Nicholas Maughan Clayton
Susanne Denise Collins
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002314319A1 publication Critical patent/AU2002314319A1/en
Abandoned legal-status Critical Current

Links

AU2002314319A 2001-06-20 2002-06-19 Use of adenosine a1 receptor agonists for the treatment of nociceptive pain Abandoned AU2002314319A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0115182.8 2001-06-20

Publications (1)

Publication Number Publication Date
AU2002314319A1 true AU2002314319A1 (en) 2003-01-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU1293101A (en) Ep4 receptor selective agonists in the treatment of osteoporosis
EP1425277B8 (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain
PL375053A1 (en) Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
HUP0401437A3 (en) Adenosine a3 receptor agonists
AU2002334870B8 (en) Combinations for the treatment of immunoinflammatory disorders
AU2003290059A1 (en) Use of cd137 antagonists for the treatment of tumors
EG25796A (en) Indanamide derivatives as muscarinic agonists
IL127947A0 (en) Pharmaceutical use of adenosine agonists
AU2002354125A1 (en) Body support device
AU2001248971A1 (en) Use of npy y1 receptor agonists in the treatment of pain conditions
AU8726201A (en) Use of CRF receptor agonists for the treatment of prophylaxis of diseases, for example neurodegenerative diseases
AU2002315522A1 (en) Receptor agonists useful for the treatment of pain
AU2002314319A1 (en) Use of adenosine a1 receptor agonists for the treatment of nociceptive pain
AU2002304883A1 (en) Device for the treatment of tumours
AU2003264297A1 (en) Use of vanilloid receptor antagonists for the treatment of pain
AU2683500A (en) Compositions for the treatment of pain
IL149266A0 (en) Use of dopamine-d3 receptor agonists for the therapy of salt-dependent hypertension
AU2696500A (en) Device for the fixation of broken bones
HUP0500698A2 (en) Use of an ascomycin for the treatment of blepharitis
AU2002366272A1 (en) Edg-receptor agonist for the treatment of hypertension
AU2002350513A1 (en) Use of solasonine for the treatment of skin tumors
AU2002226056A1 (en) Muscarinic receptor agonists
AU2003244633A1 (en) Methods for the treatment of sinusitis
AU2003245995A1 (en) Use of gaba-c receptor antagonists for the treatment of myopia
AU2001272650A1 (en) Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia